Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.47%
#2 Status Status +17.94%
#3 GoPlus Security GoPlus Security +14.03%
#4 Ontology Gas Ontology Gas +11.14%
#5 Fake World Assets Fake World Assets +9.28%
#6 DMT-NAT DMT-NAT +9.09%
#7 o1.exchange o1.exchange +7.20%
#8 Provenance Blockchain Provenance Blockchain +7.18%
#9 Nillion Nillion +7.03%
#10 Pons Pons +6.71%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
HealthWarehouse.com, Inc. HealthWarehouse.com, Inc.

HealthWarehouse.com, Inc.

HEWA
Pozycja w akcjach #34074
HealthWarehouse.com, Inc. functions as a digital and direct-mail pharmaceutical... HealthWarehouse.com, Inc. functions as a digital and direct-mail pharmaceutical service. Its offerings encompass a broad spectrum of pharmaceutical items, including generic and brand-name prescription drugs, specialized medications for pets, and a variety of over-the-counter remedies and goods. The company serves customers across all 50 U.S. states and the District of Columbia, specifically targeting the market for prescription drugs paid for directly by consumers. Sales are conducted directly to individual consumers via its online platform. Its corporate headquarters are situated in Florence, Kentucky.
Cena akcji
$0.11
Ostatnia synchronizacja: 2026-08-13
Kapitalizacja rynkowa
$6.29M
Zmiana (1 dzień)
10.00%
Zmiana (1 rok)
-33.13%
Kraj
US
Handel HealthWarehouse.com, Inc. (HEWA)

Kategoria

Healthcare
Zyski dla HealthWarehouse.com, Inc. (HEWA)
Zyski w 2026 TTM: 0
Według najnowszych raportów finansowych HealthWarehouse.com, Inc., obecny zysk firmy wynosi 0. W roku 2026 firma osiągnęła zysk w wysokości 0, równa się zysku z roku 2026, który wynosił 0. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy HealthWarehouse.com, Inc. od 2026 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
Za mało danych dla podanych dat.
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US